MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
atherosclerosis
Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.
Posted inClinical Trials, Metabolism
Innovative Treatment for Hypertension: One Shot Every Quarter or Even Six Months
Arterial hypertension is waiting for a major pharmacological breakthrough. Hundreds of millions of people will be saved.
